Bone Tumor Reference Centre Data Access Committee

Request Access

Dataset ID	Description	Technology	Samples
EGAD00001007509	Longitudinal genome-sequencing analysis of 12 patients with metastatic or refractory osteosarcoma. The study was approved at the University Hospital Basel, following the approval of the ethical committee for mutational analysis of anonymized samples (“Ethikkommission beider Basel” ref. 274/12). Informed consent was obtained from all 12 patients. All tumor samples were evaluated by an experienced bone pathologist to conﬁrm the diagnosis. WES and low coverage WGS are aligned against the reference genome GRCh37. More details in the associated publication.	Illumina HiSeq 4000	72